Skip to main content
Clinical Trials/NCT07287618
NCT07287618
Recruiting
Not Applicable

Clinical Evaluation of Potassium and Ionized Calcium Tests Using the i-STAT CG8+ Cartridge With the i-STAT 1 Analyzer for Capillary Specimens

Abbott Point of Care3 sites in 1 country425 target enrollmentStarted: September 17, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
425
Locations
3
Primary Endpoint
Method Comparison for potassium (K) and ionized calcium (iCa) blood tests.

Overview

Brief Summary

The objective of this study is to compare the performance of blood tests using the i-STAT 1 System against a comparator blood analysis system.

Detailed Description

To compare the performance of the i-STAT potassium (K) and ionized calcium (iCa) tests using the i-STAT CG8+ cartridge on the i-STAT 1 analyzer to the performance of K and iCa tests on a comparator blood analysis system using results from two separate capillary specimens from each subject enrolled in the study.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Signed and dated consent form (waiver/alteration of consent, waiver of documentation of consent may be acceptable, per IRB)
  • ≥ 18 years of age

Exclusion Criteria

  • 1\. Previous enrollment in this study

Outcomes

Primary Outcomes

Method Comparison for potassium (K) and ionized calcium (iCa) blood tests.

Time Frame: Thirty (30) minutes from subject enrollment to the end of the blood draw and testing.

Specimen testing of K and iCa in mmol/L will be performed using the i-STAT CG8+ cartridge on the i-STAT analyzer and a comparator blood analysis system with prospectively collected capillary specimens. Subjects with one valid capillary result on the i-STAT CG8+ cartridge and one valid result on the comparator blood analysis system will be evaluated.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials